Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease?

Literature DB >> 20805313

Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease?

V De Re, M P Simula, A Notarpietro, V Canzonieri, R Cannizzaro, G Toffoli.

Abstract

Entities: Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20805313 DOI： 10.1136/gut.2010.209395

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

Review 1. Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies.

Authors: Valli De Re; Maria Paola Simula; Vincenzo Canzonieri; Renato Cannizzaro
Journal: Dig Dis Sci Date: 2010-07-15 Impact factor: 3.199

Review 2. Role of transglutaminase 2 in celiac disease pathogenesis.

Authors: Cornelius Klöck; Thomas R Diraimondo; Chaitan Khosla
Journal: Semin Immunopathol Date: 2012-03-22 Impact factor: 9.623

3. Peroxisome proliferator-activated receptor-γ and thymic stromal lymphopoietin are involved in the pathophysiology of childhood coeliac disease.

Authors: Erna Sziksz; Kriszta Molnár; Rita Lippai; Domonkos Pap; Anna Onody; Apor Veres-Székely; Péter Vörös; Dolóresz Szabó; Hajnalka Győrffy; Gábor Veres; Tivadar Tulassay; Adám Vannay; András Arató
Journal: Virchows Arch Date: 2014-09-04 Impact factor: 4.064

4. Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapy.

Authors: Thomas R Diraimondo; Cornelius Klöck; Chaitan Khosla
Journal: J Pharmacol Exp Ther Date: 2012-01-06 Impact factor: 4.030

Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease?

Review 1. Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies.

Review 2. Role of transglutaminase 2 in celiac disease pathogenesis.

3. Peroxisome proliferator-activated receptor-γ and thymic stromal lymphopoietin are involved in the pathophysiology of childhood coeliac disease.

4. Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapy.

Review 5. Celiac disease, inflammation and oxidative damage: a nutrigenetic approach.

Review 6. New Insights into the Pathogenesis of Celiac Disease.

7. The critical role of dysregulation of antioxidant activity and carbohydrate metabolism in celiac disease.